Recommendations for the pharmacological management of neuropathic pain: an overview and literature update
RH Dworkin, AB O'Connor, J Audette, R Baron… - Mayo Clinic …, 2010 - Elsevier
… trials of pharmacological treatments for neuropathic pain and ambiguities … Neuropathic Pain
Special Interest Group guidelines for the pharmacological management of neuropathic pain …
Special Interest Group guidelines for the pharmacological management of neuropathic pain …
Pharmacologic management of neuropathic pain: evidence-based recommendations
RH Dworkin, AB O'connor, M Backonja, JT Farrar… - Pain, 2007 - Elsevier
… were conducted under the auspices of the IASP Neuropathic Pain Special Interest Group
with additional support provided by the Neuropathic Pain Institute, both of which have received …
with additional support provided by the Neuropathic Pain Institute, both of which have received …
Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement
… The primary aim of this article is to highlight the revised neuropathic pain medication
algorithm that was created by a panel of experts within the Canadian Pain Society (CPS). …
algorithm that was created by a panel of experts within the Canadian Pain Society (CPS). …
Pharmacological management of chronic neuropathic pain–consensus statement and guidelines from the Canadian Pain Society
… Neuropathic pain (NeP), generated by disorders of the … guidelines for the pharmacological
management of NeP are … focusing on the pharmacological management of NeP were …
management of NeP are … focusing on the pharmacological management of NeP were …
Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society
DE Moulin, A Boulanger, AJ Clark… - … and Management, 2014 - Wiley Online Library
… reviews related to the pharmacological management of NeP to … its management. METHODS:
RCTs, systematic reviews and existing guidelines on the pharmacological management of …
RCTs, systematic reviews and existing guidelines on the pharmacological management of …
An update on the pharmacologic management and treatment of neuropathic pain
ME Wright, D Rizzolo - Jaapa, 2017 - journals.lww.com
… neuropathic pain management. This article focuses on managing patients with neuropathic
pain, … some of the treatment approaches also may be beneficial for patients with mixed pain. …
pain, … some of the treatment approaches also may be beneficial for patients with mixed pain. …
Pharmacologic management of neuropathic pain
DB Gordon, G Love - Pain Management Nursing, 2004 - Elsevier
… Clinically, drug treatment of neuropathic pain is often a matter of treatment trials. This article
… lesser-known treatments for neuropathic pain. Neuropathic pain is a complex phenomenon …
… lesser-known treatments for neuropathic pain. Neuropathic pain is a complex phenomenon …
Neuropathic pain: review of mechanisms and pharmacologic management
F Orza, MV Boswell, SK Rosenberg - NeuroRehabilitation, 2000 - content.iospress.com
… conceptual framework and treatment algorithm for management of neuropathic pain (Fig. 1).
… for years in the management of neuropathic pain syndromes, including diabetic neuropathy, …
… for years in the management of neuropathic pain syndromes, including diabetic neuropathy, …
Pharmacologic management part 1: better-studied neuropathic pain diseases
MM Backonja, J Serra - Pain medicine, 2004 - academic.oup.com
… pharmacologic management of neuropathic pain, we discuss three of the better-studied
neuropathic pain conditions—postherpetic neuralgia (PHN), diabetic peripheral neuropathy (…
neuropathic pain conditions—postherpetic neuralgia (PHN), diabetic peripheral neuropathy (…
The evidence for pharmacological treatment of neuropathic pain
NB Finnerup, SH Sindrup, TS Jensen - Pain, 2010 - Elsevier
… However, despite our ignorance of the underlying pain-generating mechanisms in individual
neuropathic pain patients and despite the general lack of disease-modifying drugs, there is …
neuropathic pain patients and despite the general lack of disease-modifying drugs, there is …